Sign in
Taking peopleNo phase

Brain scans of sleeping babies to study development and cerebral palsy

Studies brain MRI during natural sleep in babies at risk of cerebral palsy.

Key facts

Who runs it
Danish Research Centre for Magnetic Resonance
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy
Status
Recruiting
People taking part
200 people, planned
Started
1 Jun 2024
Expected to end
31 Dec 2027
Type of study
Observational, 2 groups
Treatments tested
  • No intervention, observational
Record updated
28 January 2026

Who can take part

The trial is looking for babies at high risk of cerebral palsy, and typically developing babies. Babies get brain MRI scans during natural sleep and tests of movement and thinking.

Age
2 Months to 11 Months
Sex
All
Disease stage
High-risk group: for example birth before 32 weeks, birth weight below 1500 g, moderate to severe brain injury, or signs such as not sitting alone by 9 months or uneven hand use. Typical group: born after 37 weeks, uneventful birth, no brain injury or neurological condition.
Main reasons for not taking part
  • Babies who cannot have an MRI, for example with a pacemaker or other implanted electronic device
  • Families who do not speak or understand Danish
  • Families who do not want to be told about unexpected MRI findings or test scores in the clinical range
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Group: 'Newborn-detectable risk-pathway'
  • Preterm birth with gestational age below 32 weeks
  • Birth weight below 1500 g
  • Moderate to severe brain injury (A label of moderate to severe brain injury was considered if there was Papile grade three to four intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition)
  • History (e.g., neonatal seizures, ECMO, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (malformations in CNS, increased tone); Group: 'Infant detectable risk-pathway'
  • Inability to sit independently by age 9 months
  • Hand function asymmetry or crawl asymmetry
  • Inability to take weight through the plantar surface of the feet
  • History (e.g., as above) or neurological risk factors; Additional inclusion criteria for inclusion in NIBS-CP for both CP-risk groups:
  • Consent to health-relevant information on clinical findings being passed on to the medical doctors in CP-EDIT and/or their primary care physician
  • Born >37 weeks
  • Uneventful birth
  • No known history of brain injury
  • No neurological condition
  • Consent to health-relevant information on clinical findings being passed on to their primary care physician or relevant medical doctors, e.g., neuropaediatrician

Who cannot take part

  • Infants have any MRI contraindications, e.g., pacemaker or other implanted electronic devices
  • Families do not speak or understand Danish
  • Families do not wish to be informed about incidental findings on the MRI, or scores within the clinical range in the neurological, motor, or cognitive assessments

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Cerebral palsy or infant development

This trial is currently available in Denmark.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Background: Early diagnosis of cerebral palsy (CP) is crucial, enabling intervention when neuroplasticity is at its highest. Magnetic resonance imaging (MRI) plays a vital role in CP diagnosis. Currently, diagnostic MRI of newborns and infants with suspected brain damage relies heavily on structural MR images. The current study aims to i) establish procedures for clinical infant and toddler MRI during natural sleep, ii) use advanced MRI sequences, such as advanced diffusion-weighted imaging (DWI), that may be more sensitive in detecting early brain damage, and iii) map relationships between early brain development, and motor function and development.

Read full original descriptionShow less

Methods: The NIBS-CP study will enroll approximately 200 infants either at risk for CP or typically developing. Infants will be followed longitudinally (for three waves) between 3 months and 2 years of age with cerebral MRI at 3 Tesla and comprehensive assessments of motor and cognitive functioning. The MRI protocol includes advanced diffusion-weighted imaging, high-resolution structural MRI, and MR spectroscopy. The motor and cognitive assessments include Hand Assessment in Infants, Alberta Infant Motor Scales, Hammersmith Infant Neurological Examination, Peabody Developmental Motor Scales, Bayley Scales of Infant Development, and Ages and Stages Questionnaires. NIBS-CP aims to establish normative material on early brain development of Danish children and conduct normative modeling of typical and atypical development to identify deviations in brain development at the level of the single child.

Discussion: Identifying predictive brain structural features of motor function and motor development is key to the future use of early MRI in the clinical work-up, as this promotes early diagnosis and (clinical) intervention strategies tailored to the individual child.

The 2 groups in the trial

  • Typically developing infants

    Born after gestational week 37, Uneventful birth, No known history of brain injury, No known neurological disorders

    Treatment: No intervention, observational

  • High Risk for Cerebral Palsy

    Recruitment through CP-EDIT (Clinical trials.gov ID: NCT05835674), inclusion criteria. 'Newborn-detectable risk-pathway'. Preterm birth with gestational age below 32 or birth weight below 1500 g and clinical concern, Moderate to severe brain injury (Papile grade 3 to 4 intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition), History (e.g. neonatal seizures, Extra Corporal Membrane Oxygenation, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (brain malformation, increased tone), Parental concern and one of the factors above 'Infant detectable risk-pathway'. Inability to sit independently by age 9 months, Hand function asymmetry or crawl asymmetry, Inability to take weight through the plantar surface of the feet, History (as above) or neurological risk factors, Parental concern and one of the factors above.

    Treatment: No intervention, observational

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy
Plain-language title
Brain scans of sleeping babies to study development and cerebral palsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06396520, who can take part
Record updated
28 January 2026